Company news

LivaNova PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical Study

March 13, 2022

LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea

February 23, 2022

LivaNova Reports Fourth-Quarter and Full-Year 2021 Results

February 22, 2022

LivaNova to Announce Fourth-Quarter and Full-Year 2021 Results

January 11, 2022

LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting

December 1, 2021

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference

November 30, 2021

LivaNova to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 22, 2021

LivaNova Comments on Decision by Court of Appeal of Milan

November 11, 2021

LivaNova to Present at the 2021 Stifel and Jefferies Healthcare Conferences

November 9, 2021

LivaNova Announces 2021 Virtual Investor Day

November 7, 2021

LivaNova Reports Third Quarter 2021 Results

November 2, 2021

LivaNova to Host Conference Call for Third Quarter 2021 Results

October 3, 2021

LivaNova to Present at the Baird 2021 Global Healthcare Conference

August 25, 2021

LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility

August 15, 2021

LivaNova Prices Offering of Ordinary Shares

August 2, 2021

LivaNova Announces Offering of Ordinary Shares

August 1, 2021

LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer

July 27, 2021

LivaNova to Host Conference Call for Second Quarter 2021 Results

June 27, 2021

LivaNova Receives FDA Approval for Clinical Study to Evaluate the aura6000 System to Treat Obstructive Sleep Apnea

June 14, 2021

LivaNova Completes Initial Closing of Heart Valve Business to Gyrus Capital

May 31, 2021

LivaNova to Present at the UBS Global Healthcare Virtual Conference

May 12, 2021

LivaNova Reports First Quarter 2021 Results

April 27, 2021

LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression

April 25, 2021

LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine

April 19, 2021

LivaNova Achieves Clinical Milestone in Heart Failure Program

April 18, 2021

LivaNova to Host Conference Call for First Quarter 2021 Results

March 24, 2021

Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors

March 16, 2021

LivaNova Reports Fourth Quarter and Full-Year 2020 Results

February 23, 2021

LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 Results

January 19, 2021

LivaNova Announces Board Appointment and Board Leadership Changes

December 6, 2020

LivaNova to Host Satellite Symposium on Advances in Neuromodulation at American Epilepsy Society AES2020 Virtual Event

December 3, 2020

LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve Business

December 2, 2020

LivaNova to Present at the Berenberg European Conference 2020

November 24, 2020

LivaNova to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 22, 2020

LivaNova to Present at the Stifel 2020 Virtual Healthcare Conference

November 9, 2020

LivaNova Reports Third Quarter 2020 Results

October 28, 2020

LivaNova Presents New Data at European Association for Cardio-Thoracic Surgery Annual Meeting Demonstrating Benefits of Perceval Sutureless Valve

October 11, 2020

LivaNova Confirms Receipt of Letter from PrimeStone Capital

October 11, 2020

LivaNova to Host Conference Call for Third Quarter 2020 Results

September 27, 2020

LivaNova to Present at the Baird 2020 Global Healthcare Conference

August 31, 2020

LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2020

August 11, 2020

LivaNova Reports Second Quarter 2020 Results

July 28, 2020

LivaNova Announces Commercial Launch of Perceval Plus Aortic Heart Valve in Europe

July 15, 2020

LivaNova Announces Publication Detailing the Design of the RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression

July 6, 2020

LivaNova to Host Conference Call for Second Quarter 2020 Results

June 28, 2020

LivaNova Announces Pricing of Private Offering of $250 Million of 3.00% Cash Exchangeable Senior Notes Due 2025

June 11, 2020

LivaNova Announces Proposed Private Offering of $250 Million of Cash Exchangeable Senior Notes

June 10, 2020

LivaNova Announces New Senior Secured Credit Facility

June 10, 2020

LivaNova to Present at the Jefferies Virtual Healthcare Conference

May 31, 2020

New Data on LivaNova Perceval Sutureless Aortic Valve Show Consistent Outcomes, Lower Procedure Times Compared to Sutured Valves

May 27, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 38 decks. Every deck is listed under its year.